Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket

Shares of Dermata Therapeutics, Inc. DRMA rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis.

Dermata Therapeutics shares jumped 57.3% to $0.9601 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • Ainos, Inc.AIMD gained 142.6% to $4.20 in pre-market trading after falling more than 12% on Thursday.
  • Safe and Green Development Corporation SGD shares rose 34.5% to $1.83 in pre-market trading. Safe And Green Development recently issued an update on LOI for acquisition of Xene AI Software platform.
  • Pinstripes Holdings Inc. PNST shares gained 17.4% to $6.18 in pre-market trading after dipping over 35% on Thursday.
  • Fusion Pharmaceuticals Inc. FUSN shares climbed 12.6% to $9.50 in pre-market trading. Fusion Pharmaceuticals said it has achieved alignment with the FDA on a protocol and development plan for FPI-2265.
  • Inhibikase Therapeutics, Inc. IKT shares gained 10.5% to $1.48 in pre-market trading.
  • Intelligent Bio Solutions Inc. INBS shares rose 10.2% to $0.33 in pre-market trading after falling around 5% on Thursday. Intelligent Bio Solutions recently received National Association of Testing Authorities accreditation for its Intelligent Fingerprinting Drug Screening Solution.
  • Inspire Veterinary Partners, Inc. IVP gained 10.1% to $0.3799 in pre-market trading. Inspire Veterinary Partners recently announced the Opening of Newly Relocated and expanded family pet care animal hospital in Sugarland, Texas.
  • MMTec, Inc. MTC shares rose 8.2% to $2.25 in pre-market trading after surging around 15% on Thursday.
  • Biora Therapeutics, Inc. BIOR gained 7.4% to $1.45 in pre-market trading.

Losers

  • Applied Therapeutics, Inc. APLT shares fell 30.1% to $2.65 in pre-market trading after reporting topline results from ARISE-HF Phase 3 study of AT-001 in diabetic cardiomyopathy.
  • Smart for Life, Inc. SMFL shares fell 24.6% to $1.41 in pre-market trading after jumping around 15% on Thursday.
  • Alaunos Therapeutics, Inc. TCRT shares fell 21.7% to $0.0994 in pre-market trading after jumping 56% on Thursday.
  • CISO Global Inc. CISO shares fell 20.7% to $0.0829 in pre-market trading. CISO Global said the Nasdaq has determined to delist securities from Nasdaq.
  • Avenue Therapeutics, Inc. ATXI shares fell 20.7% to $0.2714 in pre-market trading. Avenue Therapeutics shares jumped over 94% on Thursday after the company announced it reached a final agreement with the FDA for the Phase 3 safety study for IV tramadol.
  • E-Home Household Service Holdings Limited EJH shares fell 20.5% to $0.6180 in pre-market trading after dipping over 47% on Thursday.
  • Verb Technology Company, Inc. VERB shares fell 16.9% to $0.1350 in pre-market trading. On Dec. 29, Verb Technology Company entered into a securities purchase agreement with Streeterville Capital where company sold and investor purchased 3,000 shares of the company's newly designated non-convertible Series C preferred stock for $3 million.
  • Voyager Therapeutics, Inc. VYGR fell 16.6% to $9.04 in pre-market trading. Voyager Therapeutics priced its public offering of 7,777,778 common shares at $9 per share.
  • KORE Group Holdings, Inc. KORE shares fell 16.4% to $1.02 in pre-market trading after jumping over 60% on Thursday.
  • Medical Properties Trust, Inc. MPW fell 14.2% to $4.29 in pre-market trading after the company issued an update on Steward Health Care. Keybanc analyst Austin Wurschmidt downgraded Medical Properties Trust from Overweight to Sector Weight.

 

Now Read This: Costco Wholesale, Constellation Brands And 3 Stocks To Watch Heading Into Friday

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...